| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.1M | -6.0% |
| Cost of Revenue | $5.4M | +2.2% |
| Gross Profit | $7.7M | -10.9% |
| R&D Expense | $436K | -28.6% |
| SG&A Expense | $3.7M | -6.9% |
| Operating Income | -$956K | — |
| Income Tax | $0 | — |
| Net Income | -$908K | — |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | -12.9% |
| Accounts Receivable | $1.4M | -6.8% |
| Inventory | $875K | +6.6% |
| Current Assets | $4.6M | -7.2% |
| Total Assets | $17.8M | +3.9% |
| Current Liabilities | $4.0M | +19.4% |
| Long-term Debt | $1.9M | -12.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $620K | -2.9% |
| Capital Expenditures | $534K | -25.9% |
| Investing Cash Flow | -$534K | +22.0% |
| Financing Cash Flow | -$276K | -89.9% |
| Free Cash Flow | $86K | +204.3% |
| $14.1M |
| +10.4% |
| Stockholders' Equity | $3.7M | -15.1% |